Quick Answer
PALISADE BIO, INC. reported Net Income of -$16.78 million for fiscal year 2025.
PALISADE BIO, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$16.78M | -16.2% |
| 2024 | -$14.44M | -17.4% |
| 2023 | -$12.30M | +13.7% |
| 2022 | -$14.26M | +46.4% |
| 2021 | -$26.62M | -157.9% |
| 2020 | -$10.32M | -23.6% |
| 2019 | -$8.35M | -69.6% |
| 2018 | -$4.92M | +68.6% |
| 2017 | -$15.67M | +25.7% |
| 2016 | -$21.07M | -0.8% |
| 2015 | -$20.90M | +7.6% |
| 2014 | -$22.63M | -14.1% |
| 2013 | -$19.83M | -95.9% |
| 2012 | -$10.12M | +19.1% |
| 2011 | -$12.52M | +31.9% |
| 2010 | -$18.39M | -77.4% |
| 2009 | -$10.36M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.87M | +17.8% | -3.0% |
| June 30, 2025 | -$2.78M | +31.8% | -24.8% |
| March 31, 2025 | -$2.23M | +36.8% | +36.0% |
| September 30, 2024 | -$3.49M | +3.0% | +14.5% |
| June 30, 2024 | -$4.08M | -20.2% | -15.7% |
| March 31, 2024 | -$3.53M | -50.7% | +1.9% |
| September 30, 2023 | -$3.60M | +9.9% | -6.0% |
| June 30, 2023 | -$3.39M | -44.8% | -45.0% |
- PALISADE BIO, INC. showed a decrease of -16.2% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, PALISADE BIO, INC.’s net income has declined by 61.9% (from -$10.36 million to -$16.78 million).
- The most recent figure is from PALISADE BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: